A new study conducted by scientists at the University of Sheffield in collaboration with researchers from UT Southwestern Medical Center in the U.S. has found a protein that could help guide which cells chemotherapies target. The findings, published in Molecular Cell, open up a promising new avenue for research into treatments that can aggressively target tumors while preserving patients' long-term quality of life.